Canaccord Genuity Starts Pacira Pharmaceuticals (PCRX) at Buy
Tweet
Share
E-mailGet Alerts PCRX Hot Sheet
Price: $25.02 -2.19%
Rating Summary:
11 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 10
Rating Summary:
11 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 11 | New: 10
Join SI Premium – FREE
Canaccord Genuity initiated coverage on Pacira Pharmaceuticals (NASDAQ: PCRX) with a Buy rating and a price target of $109.00.
For an analyst ratings summary and ratings history on Pacira Pharmaceuticals click here. For more ratings news on Pacira Pharmaceuticals click here.
Shares of Pacira Pharmaceuticals closed at $88.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Starts Chuangxin Industries Holdings (2788:HK) at Buy
- Piper Sandler Starts Guidewire (GWRE) at Overweight
- Morgan Stanley Starts Csquare Inc (CSQR) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
